Clinical Trial Update: Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of Sacubitril/Valsartan on reduced right ventricular ejection fraction in patients with connective tissue diseases an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Diseases
• Myocardial Injury
• Right Ventricular Dysfunction

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: RenJi Hospital | Conditions: Myocardial Injury, Connective Tissue Diseases | Phase 4 | Status: UNKNOWN